CYTEGRITY
Mark Identification

CYTEGRITY

Serial Number

98232757

Filing Date

Oct 20, 2023

Trademark by

CSL BEHRING GENE THERAPY INC.

Classification Information

Cell lines for scientific and research use; Cells for scientific, laboratory or medical research; Biological preparations, namely, viral vectors and gene vectors for scientific, laboratory or medical research; Cell lines; cell lines for gene expression, and for synthesis of biological compounds; cells for gene expression and for synthesis of biological compounds; viral vectors

Chemicals

Cell lines for medical purposes; Cells for medical or clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating cancer, tumors, genetic diseases, immunodeficiency conditions, stem cell transplantation, and transplant medicine; Biological preparations, namely, viral vectors and gene therapy vectors for therapeutic use and clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for treating a wide range of diseases, illnesses or conditions; Cell lines for medical purposes, namely, cell therapy; Cell lines for medical purposes, namely, immunotherapy; Cell lines for medical purposes, namely, for use as therapeutics to repair, replace or preserve cells and tissues; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating genetically engineered tissues and for treating transplant conditions; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating viral and infectious diseases; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; viral vectors for gene therapy; gene therapy vectors

Pharmaceuticals